English | Español

Astellas Pharma Us, Inc.
Carol Ostrow | Dec 3, 2017

Astellas will present AML findings at American Society of Hematology conference
Carrie Bradon | Dec 1, 2017

Astellas study shows women with overactive bladder symptoms use unconventional methods
Carrie Bradon | Nov 25, 2017

Astellas Oncology names C3 Prize winners
Marian Johns | Nov 19, 2017

Astellas receives perfect score on Corporate Equality Index for fourth consecutive year
Marian Johns | Oct 22, 2017

FDA grants fast-track status to Astellas' acute myeloid leukemia drug
Marian Johns | Oct 19, 2017

Astellas Pharma, Seattle Genetics begin clinical trial for bladder cancer treatment
Robert Hadley | Jul 7, 2017

Astellas says gilteritinib may be long-sought treatment in certain acute myeloid leukemia cases
Robert Hadley | Jun 22, 2017

Phase 3 trial of Pfizer’s prostate cancer drug could yield results two years early

Trending
+ Technology/Innovation
Patient Daily News Service | Oct 9, 2025

Babylon Health collapse raises questions about AI claims across industries
Patient Daily | Oct 9, 2025

Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'
Patient Daily | Oct 9, 2025

AI takes center stage at ASCENT ENT conference, reshaping marketing and operations
+ Pharmaceuticals
Patient Daily | Oct 7, 2025

Patients Rising co-founder on 340B drug pricing program: ‘Patients are getting screwed when it comes to their collection practices’